Statera Biopharma, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Statera Biopharma, Inc. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $8.73 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2022-11-14
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-09-30 was $2.76M.
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-06-30 was $3.39M, a 138.99% increase year-over-year.
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-03-31 was $2.57M, a 247.99% increase year-over-year.
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-12-31 was $371.63K, a 18.21% increase year-over-year.
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was $1.00M, a 256.66% increase from fiscal 2020.
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $280.84K, a 42.90% increase from fiscal 2019.
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $196.52K.
- Statera Biopharma, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was -$325.83K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $6.15M derived: sum of 2 quarters · filed 2022-11-14 | $8.73M 10-Q · filed 2022-11-14 | $9.10M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2022-06-30 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | $5.96M 10-Q · filed 2022-10-28 | $6.33M derived: sum of 3 quarters · filed 2022-10-28 | $4.81M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2022-03-31 | $2.57M 10-Q · filed 2022-10-21 | $2.95M derived: sum of 2 quarters · filed 2022-10-21 | $1.42M derived: sum of 3 quarters · filed 2022-11-14 | $2.84M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-12-31 | $371.63K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | -$1.16M derived: sum of 2 quarters · filed 2022-11-14 | $262.12K derived: sum of 3 quarters · filed 2022-11-14 | $1.00M 10-K · filed 2022-10-06 | ||||
| 2021-09-30 | -$1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$109.51K derived: sum of 2 quarters · filed 2022-11-14 | $629.99K 10-Q · filed 2022-11-14 | $540.83K 10-Q · filed 2021-11-15 | $944.39K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | $2.16M 10-Q · filed 2022-10-28 | -$8.55K 10-Q · filed 2021-08-16 | $2.47M derived: sum of 3 quarters · filed 2022-10-28 | $2.46M derived: sum of 4 quarters · filed 2022-10-28 | |||
| 2021-03-31 | $739.51K 10-Q · filed 2022-10-21 | $209.46K 10-Q · filed 2021-05-14 | $1.05M derived: sum of 2 quarters · filed 2022-10-21 | $1.04M derived: sum of 3 quarters · filed 2022-10-21 | $1.02M derived: sum of 4 quarters · filed 2022-10-21 | |||
| 2020-12-31 | $314.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $300.50K derived: sum of 2 quarters · filed 2022-10-06 | $276.55K derived: sum of 3 quarters · filed 2022-10-06 | $280.84K 10-K · filed 2022-10-06 | -$225.17K 10-K · filed 2021-03-22 | |||
| 2020-09-30 | -$13.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$37.85K derived: sum of 2 quarters · filed 2021-11-15 | -$33.56K 10-Q · filed 2021-11-15 | -$54.60K 10-Q · filed 2020-11-16 | $469.46K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$23.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$19.66K 10-Q · filed 2021-08-16 | $483.36K derived: sum of 3 quarters · filed 2021-08-16 | $143.41K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $4.29K 10-Q · filed 2021-05-14 | $507.31K derived: sum of 2 quarters · filed 2021-05-14 | $167.36K derived: sum of 3 quarters · filed 2021-05-14 | $203.89K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $503.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $163.07K derived: sum of 2 quarters · filed 2021-03-22 | $199.60K derived: sum of 3 quarters · filed 2021-03-22 | $196.52K 10-K · filed 2021-03-22 | $664.52K 10-K · filed 2020-04-15 | |||
| 2019-09-30 | -$339.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$303.42K derived: sum of 2 quarters · filed 2020-11-16 | -$306.50K 10-Q · filed 2020-11-16 | -$822.74K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $36.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $33.45K 10-Q · filed 2020-08-14 | -$482.78K derived: sum of 3 quarters · filed 2020-08-14 | -$552.45K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$3.08K 10-Q · filed 2020-05-15 | -$519.32K derived: sum of 2 quarters · filed 2020-05-15 | -$588.98K derived: sum of 3 quarters · filed 2020-05-15 | -$772.93K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$516.24K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-15 | -$585.90K derived: sum of 2 quarters · filed 2020-04-15 | -$769.85K derived: sum of 3 quarters · filed 2020-04-15 | -$325.83K 10-K · filed 2020-04-15 | ||||
| 2018-09-30 | -$69.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$253.62K derived: sum of 2 quarters · filed 2019-11-14 | $190.41K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | -$183.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $260.07K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $444.02K 10-Q · filed 2019-05-15 | |||||||
| 2017-09-30 | -$250.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$323.55K derived: sum of 2 quarters · filed 2018-11-14 | -$944.76K 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | -$72.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$694.17K 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | -$621.22K 10-Q · filed 2018-05-15 | |||||||
| 2016-09-30 | -$51.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$662.10K derived: sum of 2 quarters · filed 2017-11-14 | -$393.75K 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | -$611.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$342.68K 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | $268.36K 10-Q · filed 2017-05-15 | |||||||
| 2015-09-30 | $115.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$301.32K derived: sum of 2 quarters · filed 2016-11-14 | $10.60K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$416.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$104.91K 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | $311.92K 10-Q · filed 2016-05-16 | |||||||
| 2014-09-30 | $112.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $64.80K 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | -$47.25K 10-Q · filed 2015-08-12 | |||||||
| 2012-12-31 | $740.72K 10-K · filed 2013-03-18 | |||||||
| 2011-12-31 | $845.34K 10-K · filed 2013-03-18 | |||||||
| 2010-12-31 | $29.70K 10-K · filed 2013-03-18 |